Zhouwei Y. Wu

Haining Road 100
Shanghai, 200080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Real-world outcomes of deucravacitinib in Chinese plaque psoriasis patients: a 24-week prospective study.

Real-world outcomes of deucravacitinib in Chinese plaque psoriasis patients: a 24-week prospective study.

Journal: The Journal of dermatological treatment

Published: March 02, 2026

Response to Dr Turkmen "Abrocitinib safety in geriatric patients: The need for a holistic assessment".

Response to Dr Turkmen "Abrocitinib safety in geriatric patients: The need for a holistic assessment".

Journal: Journal of the American Academy of Dermatology

Published: February 23, 2026

SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 study.

SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 study.

Journal: Frontiers in immunology

Published: February 13, 2026

Keratinocyte-derived Exosomal LKB1 Drives Vitiligo Progression by Activating CD8+ T Cells.

Keratinocyte-derived Exosomal LKB1 Drives Vitiligo Progression by Activating CD8+ T Cells.

Journal: Inflammation

Published: November 04, 2025

Eggshell fragments as a high-yield diagnostic target in microscopic examination of scabies: A retrospective study.

Eggshell fragments as a high-yield diagnostic target in microscopic examination of scabies: A retrospective study.

Journal: Journal of the American Academy of Dermatology

Published: October 06, 2025

Real-World Characteristics, Treatment Patterns, and Outcomes in Adult Patients Receiving Abrocitinib for Atopic Dermatitis in China: Interim Analysis from the AHEAD Registry.

Real-World Characteristics, Treatment Patterns, and Outcomes in Adult Patients Receiving Abrocitinib for Atopic Dermatitis in China: Interim Analysis from the AHEAD Registry.

Journal: Dermatology and therapy

Published: September 27, 2025

Efficacy and safety of abrocitinib in elderly Chinese patients with moderate-to-severe atopic dermatitis: A single-center, retrospective study.

Efficacy and safety of abrocitinib in elderly Chinese patients with moderate-to-severe atopic dermatitis: A single-center, retrospective study.

Journal: Journal of the American Academy of Dermatology

Published: June 09, 2025

Multiple grouped brown-red nodules on the lower leg.

Multiple grouped brown-red nodules on the lower leg.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: June 03, 2025

Itchy bruising in a 5-year-old girl.

Itchy bruising in a 5-year-old girl.

Journal: Clinical and experimental dermatology

Published: March 31, 2025

Successful Treatment of Eosinophilic Pustular Folliculitis With Dupilumab in a 9-Year-Old Boy.

Successful Treatment of Eosinophilic Pustular Folliculitis With Dupilumab in a 9-Year-Old Boy.

Journal: Pediatric dermatology

Published: October 31, 2024

Abrocitinib interferes with the performance of T-SPOT.TB assay for latent tuberculosis reactivation: An in vitro study.

Abrocitinib interferes with the performance of T-SPOT.TB assay for latent tuberculosis reactivation: An in vitro study.

Journal: Journal of the American Academy of Dermatology

Published: October 18, 2024

CCR7+ dendritic cells expressing both IL-23A and IL-12B potentially contribute to psoriasis relapse.

CCR7+ dendritic cells expressing both IL-23A and IL-12B potentially contribute to psoriasis relapse.

Journal: Nature communications

Published: June 17, 2024

Showing 1-12 of 64

Last Updated: 09/26/2026